AU2003248907B2 - Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds - Google Patents
Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds Download PDFInfo
- Publication number
- AU2003248907B2 AU2003248907B2 AU2003248907A AU2003248907A AU2003248907B2 AU 2003248907 B2 AU2003248907 B2 AU 2003248907B2 AU 2003248907 A AU2003248907 A AU 2003248907A AU 2003248907 A AU2003248907 A AU 2003248907A AU 2003248907 B2 AU2003248907 B2 AU 2003248907B2
- Authority
- AU
- Australia
- Prior art keywords
- pyrrolo
- 6alkyl
- ethoxy
- effective amount
- 7trimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39473402P | 2002-07-11 | 2002-07-11 | |
| US60/394,734 | 2002-07-11 | ||
| PCT/US2003/021493 WO2004006836A2 (en) | 2002-07-11 | 2003-07-08 | Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003248907A1 AU2003248907A1 (en) | 2004-02-02 |
| AU2003248907B2 true AU2003248907B2 (en) | 2007-04-26 |
Family
ID=30115760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003248907A Ceased AU2003248907B2 (en) | 2002-07-11 | 2003-07-08 | Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7465730B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1539168A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005536507A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003248907B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2492022A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004006836A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR047759A1 (es) | 2003-09-26 | 2006-02-22 | Vertex Pharma | Derivados de fenil - piperazina como moduladores de receptores muscarnicos |
| GB0405200D0 (en) * | 2004-03-08 | 2004-04-21 | Pfizer Ltd | Combinations comprising alpha-2-delta ligands |
| AU2006294579A1 (en) | 2005-09-27 | 2007-04-05 | Myriad Genetics, Inc. | Pyrrole derivatives as therapeutic compounds |
| CN101003537A (zh) * | 2006-01-17 | 2007-07-25 | 上海恒瑞医药有限公司 | 吡咯并哒嗪类衍生物及其制备方法和用途 |
| TW200914457A (en) * | 2007-05-31 | 2009-04-01 | Kyowa Hakko Kogyo Kk | Pyrimidodiazepinone derivative |
| KR101335784B1 (ko) | 2007-09-28 | 2013-12-05 | 다이이찌 산쿄 가부시키가이샤 | 2 고리성 γ-아미노산 유도체 |
| EP3106166B1 (en) | 2008-02-29 | 2020-12-02 | VM Therapeutics LLC | Compounds for treating pain syndrome and other disorders |
| EP2313102A2 (en) | 2008-07-03 | 2011-04-27 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| GB0813144D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
| WO2010110361A1 (ja) | 2009-03-26 | 2010-09-30 | 第一三共株式会社 | 二環性γ-アミノ酸誘導体の製造方法 |
| BR112013031360B1 (pt) | 2011-06-08 | 2022-01-25 | Daiichi Sankyo Company, Limited | Método para produzir um composto |
| ES2649968T3 (es) | 2011-06-08 | 2018-01-16 | Daiichi Sankyo Company, Limited | Procedimiento de producción de un compuesto bicíclico vía transposición de Claisen |
| HUE040225T2 (hu) | 2011-12-15 | 2019-02-28 | Daiichi Sankyo Co Ltd | Eljárás biciklikus vegyület optikai elválasztására aszimmetrikus katalizátort felhasználva |
| HUE033397T2 (en) | 2012-04-10 | 2017-12-28 | Daiichi Sankyo Co Ltd | A method for the optical separation of bicyclic compounds by an enzyme |
| WO2014069626A1 (ja) * | 2012-11-01 | 2014-05-08 | 協和発酵キリン株式会社 | ピリミドジアゼピノン化合物の製造方法 |
| EP2928891B1 (en) | 2012-12-04 | 2019-02-20 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
| TWI635071B (zh) | 2013-07-08 | 2018-09-11 | 第一三共股份有限公司 | 光學活性二環γ-胺基酸衍生物及其製造方法 |
| EP3548489A1 (en) * | 2016-11-30 | 2019-10-09 | Esteve Pharmaceuticals, S.A. | Ortho substituted phenylpyrazolo- and phenylpyrrolo-pyridazine derivatives having multimodal activity against pain |
| WO2018100041A1 (en) * | 2016-11-30 | 2018-06-07 | Laboratorios Del Dr. Esteve, S.A. | Meta substituted phenylpyrazolo- and phenylpyrrolo- pyridazine derivatives having multimodal activity against pain |
| EP3630765A1 (en) * | 2017-05-30 | 2020-04-08 | Esteve Pharmaceuticals, S.A. | Substituted pyrrolidinyl and piperidinyl pyrazolopyridazine derivatives having multimodal activity against pain |
| WO2021239558A1 (en) | 2020-05-27 | 2021-12-02 | Esteve Pharmaceuticals, S.A. | Pyrazolo[1,5-a]pyrimidine derivatives having multimodal activity against pain |
| GB202106872D0 (en) * | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5622948A (en) * | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
| GB9726701D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
-
2003
- 2003-07-08 JP JP2004521592A patent/JP2005536507A/ja active Pending
- 2003-07-08 EP EP03764414A patent/EP1539168A2/en not_active Withdrawn
- 2003-07-08 US US10/520,962 patent/US7465730B2/en not_active Expired - Fee Related
- 2003-07-08 CA CA002492022A patent/CA2492022A1/en not_active Abandoned
- 2003-07-08 WO PCT/US2003/021493 patent/WO2004006836A2/en not_active Ceased
- 2003-07-08 AU AU2003248907A patent/AU2003248907B2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| Journal of Organic Chemistry (1959), 24, 551-4. * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003248907A1 (en) | 2004-02-02 |
| WO2004006836A3 (en) | 2004-04-15 |
| CA2492022A1 (en) | 2004-01-22 |
| JP2005536507A (ja) | 2005-12-02 |
| US7465730B2 (en) | 2008-12-16 |
| EP1539168A2 (en) | 2005-06-15 |
| US20060154929A1 (en) | 2006-07-13 |
| WO2004006836A2 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI542590B (zh) | 1,2-雙取代雜環化合物 | |
| US7465730B2 (en) | Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds | |
| TWI760390B (zh) | 吡唑並雜芳基類衍生物、其製備方法及其在醫藥上的應用 | |
| KR100256707B1 (ko) | 데아자푸린 유도체; 새로운 부류의 crf1 특이 리간드 | |
| CN104768932B (zh) | Pde4的杂芳基抑制剂 | |
| KR101196498B1 (ko) | 사이클린 의존성 키나제 억제제로서의 피라졸로피리미딘유도체 | |
| DE60009033T2 (de) | Tricyclische inhibitoren von poly(adp-ribose) polymerasen | |
| EP2964223B1 (en) | Compounds inhibiting leucine-rich repeat kinase enzyme activity | |
| KR100820543B1 (ko) | GSK3β억제제로서의 2-아미노-3-(알킬)-피리미돈유도체 | |
| DE69426422T2 (de) | Pyridazino-chinolin verbindungen | |
| CN100376580C (zh) | 作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶 | |
| DE60219672T2 (de) | Imidazopyridine, -pyrimidine und -triazine als gaba-a alpha 5 rezeptor subtyp liganden zur verbesserung kognitiver eigenschaften | |
| JPH11514668A (ja) | ホスホジエステラーゼ(pde)iv型および腫瘍壊死因子(tnf)阻害物質としての置換インダゾール誘導体及びその使用法 | |
| WO2016169421A1 (zh) | 咪唑并异吲哚类衍生物、其制备方法及其在医药上的应用 | |
| AU9455298A (en) | Indazole bioisostere replacement of catechol in therapeutically active compounds | |
| WO2012046030A2 (en) | Phosphodiesterase inhibitors | |
| KR20030064773A (ko) | 항염증제 | |
| CN111434662B (zh) | 卤代烯丙基胺类化合物及其应用 | |
| HUE029717T2 (en) | Tetrahydroquinazoline derivatives such as TANK (Tankirase) and PARP inhibitors | |
| JPS6136282A (ja) | 窒素を含む複素環式化合物からなる医薬品とその製造方法 | |
| US5847136A (en) | Deazapurine derivatives; a new class of CRF1 specific ligands | |
| WO1999062899A1 (en) | Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition | |
| CN101874022A (zh) | 吲唑丙烯酸酰胺化合物 | |
| CA2570046A1 (en) | Substituted triazole derivatives as oxytocin antagonists | |
| US20070099950A1 (en) | Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |